Trial Profile
Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Corticosteroids; Cyclophosphamide
- Indications Interstitial lung diseases
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 15 Apr 2022 Interim Results (n=170) published in The Journal of Rheumatology
- 04 Mar 2020 Status changed from active, no longer recruiting to completed.
- 12 Feb 2017 Status changed from recruiting to active, no longer recruiting.